Clorox Co (CLX) is overvalued and Kenvue Inc (KVUE) is overvalued.
Both trade above our estimate of their intrinsic value. KVUE is the closer of the two: -30%, against -87% for CLX.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $46.51; the price of $87.15 is 87% above that value, and 81% of that value comes from beyond year five.
Leak Score 44/100 on 2 of 12 signals
Discounting its cash flows at 7.4% (average of 3 methods) values the shares at $13.69; the price of $17.86 is 30% above that value, and 81% of that value comes from beyond year five.
Leak Score 29/100 on 5 of 12 signals
| Metric | CLX | KVUE |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $87.15 | $17.86 |
| Intrinsic value | $46.51 | $13.69 |
| Margin of safety | -87% | -30% |
| Leak Score | 44/100 (2/12) | 29/100 (5/12) |
| Market cap | $10.5B | $34.3B |
| Revenue growth, 5 years | -1.8% | 0.9% |
| Operating margin | 13.2% | 19.2% |
| Net margin | 8.7% | 10.8% |
| Return on equity | 285.6% | 15.6% |
| Debt to equity | 62.02 | 0.82 |
| P/E | 18.1x | 20.7x |
| Forward P/E | 13.9x | 14.3x |
| P/B | 117.1x | 3.3x |
| Dividend yield | 5.8% | 4.7% |